Patents by Inventor Pille HARRISON

Pille HARRISON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260108530
    Abstract: The present invention relates to compound according to Formula I: or a pharmaceutically acceptable salt thereof, or a solvate or the salt of a solvate thereof, pharmaceutical compositions comprising the same, and methods of treatment using the same, for use in the treatment of psoriatic arthritis, by administering the compound according to Formula I.
    Type: Application
    Filed: May 13, 2025
    Publication date: April 23, 2026
    Inventors: Pille Harrison, Luc Meuleners, Chantal Thérèse Tasset
  • Patent number: 12329758
    Abstract: The present invention relates to compound according to Formula I: or a pharmaceutically acceptable salt thereof, or a solvate or the salt of a solvate thereof, pharmaceutical compositions comprising the same, and methods of treatment using the same, for use in the treatment of psoriatic arthritis, by administering the compound according to Formula I.
    Type: Grant
    Filed: May 23, 2019
    Date of Patent: June 17, 2025
    Assignee: ALFASIGMA S.P.A.
    Inventors: Pille Harrison, Luc Meuleners, Chantal Thérèse Tasset
  • Publication number: 20210299135
    Abstract: The present invention relates to compound according to Formula I: or a pharmaceutically acceptable salt thereof, or a solvate or the salt of a solvate thereof, pharmaceutical compositions comprising the same, and methods of treatment using the same, for use in the treatment of psoriatic arthritis, by administering the compound according to Formula I.
    Type: Application
    Filed: May 23, 2019
    Publication date: September 30, 2021
    Inventors: Pille HARRISON, Luc MEULENERS, Chantal Thérèse TASSET
  • Publication number: 20190314382
    Abstract: The present invention relates to the use of compounds or pharmaceutical compositions comprising the same, and methods of treatment using the same, in the prophylaxis and/or treatment of alopecia areata, vitiligo, cutaneous lupus, lupus nephritis, giant cell arteritis, sarcoïdosis and/or sarcoïdosis-related conditions. In particular the compounds are JAK inhibitors.
    Type: Application
    Filed: November 9, 2017
    Publication date: October 17, 2019
    Inventors: Chantal Thérèse TASSET, Pille HARRISON, René Alexandre GALIEN, John Sargent SUNDY, John G. MCHUTCHISON, Thomas O'RIORDAN, Neelufar MOZAFFARIAN, Uptal Dinesh PATEL, Timothy R. WATKINS, David L. GOSSAGE